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AbstrACt
Objective To investigate the feasibility of undertaking a 
definitive randomised controlled trial (RCT).
setting This was a pilot, pragmatic superiority RCT with a 
qualitative element, recruiting from 14 general practitioner 
(GP) practices in England.
Participants Patients over 18 years of age presenting 
to their GP with unilateral lumbar radicular syndrome 
(LRS), defined as radicular pain and/or neurological 
symptoms originating from lumbar nerve roots, were 
eligible to participate in the study, those who did not 
have a clear understanding of the English language 
or had comorbidities preventing rehabilitation were 
ineligible.
Interventions Participants were randomised into 
early intervention physiotherapy or usual care with the 
former receiving their treatment within 2 weeks after 
randomisation and the latter 6 weeks postrandomisation. 
Both groups received a patient-centred, goal-orientated 
physiotherapy programme specific to their needs. 
Participants received up to six treatment sessions over an 
8-week period.
Outcome measures Process outcomes to determine 
the feasibility of the study and an exploratory analysis of 
patient-reported outcomes, including self-rated disability, 
pain and general health, these were collected at baseline, 
6, 12 and 26 weeks postrandomisation.
results 80 participants were recruited in 10 GP practices 
over 34 weeks and randomised to (early intervention 
physiotherapy n=42, usual care n=38). Follow-up rates at 
26 weeks were 32 (84%) in the usual care and 36 (86%) in 
the early intervention physiotherapy group. The mean area 
under the curve (larger values indicating more disability) 
for the Oswestry Disability Index over the 26 weeks was 
16.6 (SD 11.4) in the usual care group and 16.0 (SD 14.0) 
in the intervention group. A difference of −0.6 (95% CI 
−0.68 to 5.6) in favour of the intervention group.
Conclusions The results of the study suggest a full RCT is 
feasible and will provide evidence as to the optimal timing 
of physiotherapy for patients with LRS.
trial registration number NCT02618278, 
ISRCTN25018352.
IntrOduCtIOn  
Lumbar radicular syndrome (LRS) is a 
painful and disabling condition, usually of 
benign causation and in around 90% of 
cases associated with an intervertebral disc 
(IVD) prolapse.1 Symptomatic presentation 
of LRS is heterogeneous, it can be self-lim-
iting, lasting only a short time with no signif-
icant sequelae or can be a major cause of 
prolonged disability, work loss and long-term 
healthcare usage with associated costs.2 3 Life-
time prevalence of LRS is estimated to be 
between 1% and 43%4 with an annual inci-
dence of between 1% and 5%.5 
Around 75% of LRS sufferers will have 
symptom resolution by 12 weeks, alongside 
spontaneous resorption of the IVD.6 However, 
there is no reliable predictor of early, late 
or no recovery at all.7 Treatment guidelines 
strengths and limitations of this study
 ► This pilot randomised controlled trial (RCT) was con-
ducted in the primary care setting with clinical staff 
delivering the intervention.
 ► All feasibility objectives were met, including recruit-
ment and participant attrition, and so the study can 
directly inform the design and conduct of a definitive 
RCT.
 ► Participants self-referred into the study after an 
introduction from their general practitioner (a pre-
requisite for ethics approval) and so this group 
of patients may not be representative of a wider 
population.
 ► The diagnosis of lumbar radicular syndrome was 
made from the clinical history and participant symp-
tomatology and as such it is likely that there was a 
degree of diagnostic heterogeneity within the study 
sample.
 ► This was a pilot RCT and as such all analyses are 
exploratory.
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encourage initial conservative management before consid-
ering surgery. Physiotherapy for LRS is commonly employed 
in the UK for the management of LRS, however, there is a 
lack of consensus on the type, duration and timing of the 
physiotherapy intervention.8 Early intervention physio-
therapy for low back pain (LBP) has been found to improve 
patient outcomes, satisfaction and have lower healthcare 
usage and associated costs.9–11 Delayed initiation of physio-
therapy has been found to increase healthcare consump-
tion in patients with LRS.12 This suggests early treatment 
is important in terms of cost savings and prevention of 
chronic symptom development13 as increased symptom 
duration leads to worse outcomes for patients who under-
take both conservative or surgical care.14 15 Surgery for 
patients with LRS has been advocated, with optimum 
timing being between 4 weeks and 6 months after symptom 
onset.16 17 Superiority studies of surgery and conservative 
management show a quicker improvement of patient symp-
toms in surgical groups, with results at a year showing no 
significant differences.18 19 A significant number of patients 
never have any substantial relief from surgery with unsatis-
factory outcomes in over 20% of patients at 5 years.20 21 The 
timing of physiotherapy engagement for LRS has yet to be 
investigated.
AIms And ObjeCtIves
The study aim was to investigate the feasibility of under-
taking a full randomised controlled trial (RCT) to deter-
mine the effectiveness and cost-effectiveness of early 
intervention physiotherapy for patients with LRS.
Process objectives
1. Successfully set-up recruitment sites in general practi-
tioner (GP) practices.
2. Achieve a recruitment rate of seven participants per 
month.
3. Demonstrate the ability to organise 75% of physio-
therapy appointments within 2 weeks of randomisa-
tion.
4. Provide an appointment within 20 days of randomisa-
tion for >75% of participants randomised to the inter-
vention group.
5. Achieve a participant attendance at >66% of physio-
therapy appointments.
6. Achieve a participant attrition rate of <25% over the 
course of the study.
7. Achieve 80% return of patient-reported outcome mea-
sures (PROMS) at 6/52 follow-up.
research objectives
1. To test the feasibility, practicality, safety and acceptabil-
ity of the study design and protocol.
2. Demonstrate acceptability of the primary and second-
ary outcome measures to patients and clinicians.
3. To inform the sample size calculation for the definitive 
RCT.
methOds
design and setting
This was a mixed-methods study comprising an external 
pilot RCT with an embedded qualitative component in 
the form of stakeholder interviews in 14 GP practices 
in a large city in England. Known as the PhysiOtherapy 
management of LumbAr Radicular syndrome (POLAR) 
study, the pilot RCT will be presented in this paper. A 
change was made to the inclusion criteria after 1 week 
of recruitment, the upper age limit of 70 was removed 
as this excluded a number of potential participants. The 
protocol for the study has been published, including 
extensive details of methods.22
Patient and public involvement
The research question was informed directly from patient 
feedback on physiotherapy services. Current and past 
patients who have experienced LRS were involved from 
the inception to the end of the study in various ways. First, 
they were involved in developing the research question, 
iteration of the intervention and the study processes. 
They were invaluable in developing patient information 
and insight into recruitment strategies. Finally, they were 
actively involved in the interpretation of the results and 
discussions of the next stage of the study. Results will be 
distributed by email or post to participants who opted to 
receive the results at consent.
randomisation
Information from the baseline dataset was used to 
randomise the participants using a web-based system. The 
Oswestry Disability Index 2.0 (ODI)23 was used as the strat-
ification factor with three levels based on ODI severity24: 
‘mild and moderate’ (≤22%–40%), ‘severe’ (>40%–60%) 
and ‘crippled’ (>60%–80%). A blinded block size was 
used to minimise predictability. The random allocation 
sequence and block size, stratified by centre and ODI 
disability score, was independently generated by the Shef-
field Clinical Trials Research Unit .
Participants were informed of their group allocation 
within one working day of their consent and randomi-
sation. Participants were randomised to treatment at 
either 2 or 6 weeks postrandomisation, we were unable 
to blind either patients or clinicians to the treatment 
allocation as it was obvious at what time point they were 
receiving treatment. In an effort to minimise bias, both 
groups of patients received protocolised treatment based 
on the same assessment and treatment framework at the 
different time points.
Participants
Potential participants with a clinical diagnosis of LRS were 
identified by their GP and given details of the study. Each 
participating GP underwent training and was equipped 
with a diagnostic aide memoire for clinically identi-
fying patients with LRS (see online supplementary file 
1). If interested, the patient contacted a member of the 
research team who screened for eligibility and arranged 
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to meet to discuss the study. Anyone over the age of 18 
years with unilateral LRS and who could speak English 
were eligible. If they had ‘red flag’ signs or symptoms such 
as cancer, cauda equina syndrome, spinal fracture or had 
other physical or psychological disabilities preventing 
rehabilitation, they were ineligible.
recruitment and consent
Written consent was obtained by the research team after 
meeting the potential participant and confirming eligi-
bility criteria including the clinical diagnosis of LRS. 
There were three recruitment cycles, each lasting up to 
12 weeks or until 27 participants had been recruited for 
that cycle (26 for the final cycle). The remaining 8 weeks 
were used for completion of treatment. A 2-week period 
between cycles provided time to reflect and analyse the 
results from the stakeholder interviews and other feed-
back to refine the study processes as necessary.
the intervention
The intervention was protocolised and allowed the 
treating physiotherapist a range of treatment options 
within each domain. Selected options were recorded elec-
tronically for each treatment session. The goal-orientated 
physiotherapy regimen for both groups were tailored 
to the individuals’ requirements based on the informa-
tion gathered from the baseline interview data, PROMS 
and clinical assessment. Participants were assessed using 
a multidimensional approach based on seven different 
elements: psychological barriers to recovery, neurolog-
ical factors, movement restriction, understanding, condi-
tioning, movement control and pain. Individualised 
physiotherapy for LBP and LRS is known to be superior 
and more cost-effective than advice alone,25 26 it is flexible 
and directly relevant to the individual and their changing 
needs. Participants received a maximum of six sessions of 
Figure 1 POLAR Consolidated Standards of Reporting Trials flow chart.
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physiotherapy over an 8-week period, fewer if their prede-
termined goals had been achieved. A logic model has 
been developed for the intervention which can be found 
in online supplementary file 2.
treatment fidelity
Several strategies were employed to optimise fidelity, 
including a protocolised training package for the treating 
physiotherapists, standardised patient information, 
weekly feedback and support of treating physiotherapists 
and video analysis of each participating physiotherapist 
treating a study participant. The study took place in an 
National Health Service (NHS) community setting using 
three physiotherapists, already employed by the host 
service provider. The physiotherapists had a mean age of 
36 years (range 34–40 years) and a mean of 10 years post-
graduate experience (range 7–12 years). They underwent 
21 hours of training in the assessment and intervention 
and to promote and facilitate self-management, optimal 
function, pacing advice, analgesic advice together with 
equipping the patient with coping strategies.
Outcomes
Patients were asked to complete self-report and screening 
measures by post or face to face at four-time points: first, 
at the time of consent and then at 6, 12 and 26 weeks 
postrandomisation. The primary outcomes for the study 
were process outcomes as the objective was to determine 
the feasibility of carrying out a full-scale RCT. Secondary 
outcomes were the ODI, Visual Analogue Scale for back 
and leg pain, Keele STarT Back score,27 EQ-5D-5L28 and 
a self-report form focussing on functional loss, goals and 
medical history.
sample size
It has been recommended that an external pilot study 
should have at least 70 measured participants (35 
per group) when estimating the SD for a continuous 
Table 1 Baseline characteristics of POLAR participants
Early intervention physiotherapy Usual care Total
N % N % N %
Female 21 50 18 47 39 49
White 
British 
38 90 33 87 71 89
N Mean SD N Mean SD N Mean SD
Age (years) 42 47 14 38 47 13 80 47 13
Height (cm) 42 172.1 10.7 38 172.1 9.8 80 171.7 10.2
Weight (kg) 39* 81.5 14.8 38 80.6 15.7 77 81 15.2
BMI 39* 27.7 4.6 38 27.3 5.6 77 27.5 5.1
ODI score 
(%)
42 44.6 19.5 38 45.2 17.4 80 44.9 18.4
Leg pain 42 7.2 1.8 38 6.9 2.3 80 7 2.1
Back pain 42 5.4 3.3 38 6 2.6 80 5.7 3.0
EQ-5D-5L 
VAS
42 63.8 20.6 38 64.6 18.9 80 64.1 19.7
EQ-5D-5L 
utility score
42 0.44 0.29 38 0.52 0.25 80 0.48 0.27
Keele 
STarT Back
42 5.7 2.0 38 5.7 1.8 80 5.7 1.9
Keele 
STarT Back 
subscore
42 2.0 1.5 38 2.7 1.3 80 2.8 1.4
Time to 
treatment 
(days)†
38 11.1 10.5 31 43.6 8.9 69 25.7 19.0
N Median IQR N Median IQR N Median IQR
Symptoms 
duration 
(days)
42 92 276 38 61 51 80 77 203
*Three missing values.
†Time between randomisation and first scheduled treatment session.
BMI, body mass index; ODI, Oswestry Disability Index; VAS, Visual Analogue Scale, EQ-5D-5L, EuroQol-5 Dimensions.
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outcome.29 A sample size of 80 patients, with approx-
imately 10% allowance for loss to follow-up allows the 
SD of an outcome to be estimated to within a precision 
of approximately ±16% of its true underlying value with 
95% CI.
results
The flow chart of the participant journey for the POLAR 
study can be viewed in figure 1. Ninety potential partici-
pants who were given details of the study by their respec-
tive GPs contacted the research team. Ten were excluded 
as they either did not meet the inclusion criteria or refused 
to be randomised, with 80 going on to be randomised 
from 10 different primary care GP practices.
baseline characteristics
The baseline characteristics of all participants, by group 
can be found in table 1. This illustrates the comparability 
of the two arms with no evidence of selection bias. The 
groups were well matched for demographic factors such 
as age, gender and body mass index as well as levels of 
disability, pain in leg and back, risk of chronicity and 
general health status. However, there was evidence of a 
difference in the EQ-5D utility scores which is attributable 
to chance as all participants were randomised. The early 
intervention physiotherapy group had longer symptom 
duration going into the study.
Process results
The POLAR study is a pilot trial and outlined below are 
the results of the feasibility objectives.
Set-up of recruitment sites in primary care
Twenty GP practices were initially approached to take part 
in the study, with 10 agreeing to participate. Towards the 
end of the second tranche of recruitment, it was evident 
that one practice was recruiting a large number of partic-
ipants and a decision was made to enrol new recruitment 
centres. Seven further GP practices were, therefore, 
approached, with four agreeing to participate.
Recruitment rate
Eighty participants were recruited between the period 1 
March 2016 and 7 November 2016 with a recruitment rate 
of 2.4 participants per week or 9.6 participants per month 
which enabled recruitment to end earlier than antici-
pated. Forty-two participants were randomised into the 
early intervention group and 38 in the usual care group.
Organisation of physiotherapy appointments
The target of 75% of physiotherapy appointments being 
made within 2 weeks of randomisation was surpassed in 
both groups. One hundred per cent (42/42) (95% CI 
92% to 100%) of early intervention physiotherapy 
participants received their appointment within 20 days 
of randomisation and 38/38 (95% CI 91% to 100%) in 
the usual care group. This illustrates the feasibility of 
making appointments for participants at short notice.
The feasibility of intervention delivery
A key feasibility parameter was the ability for at least 75% 
of early intervention physiotherapy participants to be seen 
by a physiotherapist, within 20 days of randomisation. One 
hundred per cent (42/42) (95% CI 92% to 100%) of partic-
ipants reached this target, with a mean of 14.1 days between 
randomisation and first treatment session.
Participant treatment session attendance
The mean attendance rate for physiotherapy appointments 
in both groups was 92.6% (SD 16.2), 93.8% (SD 12.6) for 
the intervention group physiotherapy and 91.1% (SD 19.8) 
in the usual care group. All surpassed the a priori target 
of greater than 66% attendance. The mean number of 
treatment sessions received by the intervention group was 4 
(SD=1) and 3 in the usual care group (SD=2).
Participant attrition
Eighty participants agreed to take part in the study. The 
intervention group attrition rate was 14% (6/42) (95% CI 
7% to 28%) and in the usual care group it was 16% (6/38) 
(95% CI 7% to 30%) at 26 weeks follow-up. The overall 
attrition rate for drop-out of participants was 15% (95% 
CI 9% to 24%), all within the a priori limit set at 25%.
Figure 2 Leg pain and ODI scores across groups. ODI, Oswestry Disability Index.
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Outcome measure return
The outcome measure return rates surpassed expecta-
tions of 80% at 6 weeks and were as follows: 38/42 (91%; 
95% CI 78% to 96%) at 6 weeks postrandomisation for 
the intervention group and 35/38 (92%; 95% CI 79% to 
97%) for the usual care group.
research results
Analysis of key clinical outcomes
Figure 2 shows the leg pain and ODI scores (likely 
primary outcome measures for definitive RCT) for partic-
ipants with all four assessments completed. The blue 
line illustrates the increased rate of recovery in the early 
intervention physiotherapy group up to 6 weeks. When 
the usual care group begins their physiotherapy, the rate 
of recovery assimilates and by 12 weeks both groups have 
very similar scores. The descriptive statistics for all partic-
ipants by group and time point can be found in table 2. 
Two participants underwent lumbar microdiscectomy 
surgery for their LRS. Both participants had completed 
their respective courses of physiotherapy before under-
going surgery. S05/005 (usual care) failed to make signif-
icant improvements to their pain and with a severe level 
of pain and disability, surgery was undertaken. S06/027 
(early intervention physiotherapy) had made signifi-
cant improvements with physiotherapy, improving by 
over 20 points on the ODI, but required surgery due to 
‘impending’ cauda equina syndrome.
The feasibility, practicality, safety and acceptability of the study 
design and protocol
The feasibility of the study has been suggested by the 
results of the feasibility parameters. There were several 
adjustments made to the processes of the study which 
were made possible by the breaks in recruitment. These 
included a brief weekly email to all participating GPs 
to remind them of the study and improve the clarity 
of inclusion and exclusion criteria. A change to the 
process of administering the 6-week outcome measures 
was necessary, after the physiotherapists reported it too 
time consuming to administer. There were no changes 
made to the intervention, which appeared to be well 
received by both participants and clinicians alike. 
There were no adverse events or serious adverse events 
(SAEs) associated with the intervention or the study 
processes.
Harms
There was one SAE during the course of the study in the 
early intervention physiotherapy group. The SAE rate was 
2% (1/42) in the early intervention physiotherapy group 
and 0% (0/38) in the usual care group a difference of 
2% (95% CI −7% to 12%). The participant was hospital-
ised after suffering a cerebrovascular accident related to 
pre-existing vascular hypertension. The participant had 
completed their physiotherapy intervention 2 weeks prior 
and made a full recovery at 6 months. This was reported 
to the ethics committee and Trial Management Group. T
ab
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Table 3 Intervention domains and components frequency table
Domain
No of participants 
receiving 
component n=69
Method of 
assessment Treatment options
Frequency of 
component 
used %
Psychological 
barriers to 
recovery32–34
47 (68%) Keele STarT Back
clinical 
interview and 
history
1. Treatment of kinesiophobia with graded exposure, 
education and movement re-education
16 1.3
2. Treatment of hypervigilance with education, 
distraction and desensitisation
17 1.4
3. Treatment of faulty beliefs about pain, LRS, treatment 
and/or prognosis with education and self-management 
strategies
38 3.2
4. Treatment of Iatrogenic beliefs and corresponding 
avoidance behaviours with education and movement 
re-education
3 0.2
5. Treatment of aspects of work as a barrier to recovery 
and treatment with ergonomic advice and practice
15 1.2
6. Identification of financial barriers to recovery and 
signposting, for example, debt management
15 1.2
7. Identification of emotional barriers to recovery and 
signposting to appropriate therapy, for example, GP/
psychology
57 4.7
Neurological35–38 39 (58%) Clinical 
assessment
1. Neural interface mobilisation 98 8.1
2. Functional neurological movement re-education 7 0.6
Movement 
restriction39
59 (86%) Clinical 
assessment
1. Flexion mobilisation (grades 2–4) 68 5.6
2. Side flexion mobilisation (grades 2–4) 5 0.4
3. Extension mobilisation (grades 2–4) 15 1.2
4. Rotation mobilisation (grades 2–4) 41 3.4
5. Flexion+side flexion mobilisation (grades 2–4) 11 0.9
6. Flexion+side+flexion+rotation mobilisation (grades 2–4) 62 5.2
7. Extension+side flexion mobilisation (grades 2–4) 0 0
8. Manipulation (grade 5) 0 0
9. Seated mobilisation with movement (MWM) 16 1.3
10. Standing MWM 16 1.3
11. Mobilisation into functional position 14 1.2
12. Muscle stretches 61 5.1
13. Functional movement re-education 7 0.6
Understanding40 66 (96%) 1. Management of erroneous believes relating to LRS 
provide education to help eradicate these beliefs
57 4.7
2. Pacing behaviours 53 4.4
3. Goal attainment 58 4.8
4. Health Promotion 80 6.6
5. Identification and treatment of central sensitisation-
liaison with GP/pain clinic
8 0.7
6. Identification and treatment of peripheral sensitisation-
liaison with GP/pain clinic
7 0.6
Conditioning41 42 63 (91%) Self-assessment 
answers, clinical 
interview and 
history
1. Cardiovascular and conditioning exercise relevant to 
patients’ goals
83 6.9
2. Function-specific stretches 39 3.2
3. Function-specific strengthening 62 5.2
4. Ergonomic advice 14 1.2
5. Ergonomic practice 6 0.5
6. Group exercise 0 0.0
7. Perturbation training 7 0.6
Continued
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Acceptability of the primary and secondary outcome measures to 
patients and clinicians
The importance of examining acceptability of the 
outcome measures, processes and the intervention was a 
key area of investigation for the study, and the pilot trial 
included a qualitative element to explore these aspects. 
Details of the qualitative aspects of the study will be 
reported in forthcoming papers. However, in summary, 
the key processes necessary for implementation and eval-
uation of the study were reported to be acceptable by all 
stakeholders.
Fidelity
Physiotherapists recorded the components of their 
treatment sessions at each patient encounter in order 
to enhance and measure treatment fidelity. Participants 
in the early intervention physiotherapy group had a 
mean of four treatment sessions and those participants 
in the usual care group three sessions. There were 269 
physiotherapy sessions carried out as part of the POLAR 
study with 1267 component parts (table 3), 36 (3%) of 
which outside the protocolled treatment framework. 
The components outside the protocol consisted of 
three sessions of acupuncture and exercise other than 
that in the protocol. Video analysis was carried out 
independently on a purposive sample of five treatment 
sessions using a fidelity assessment tool developed by 
the lead author, clinical colleagues and PPIE (Patient 
and Public Involvement and Engagement) represen-
tatives. The maximum score for ‘essential’ aspects of 
fidelity was 15/15. The median score for the videos was 
14/15 (93%) with a range of 13–15 (87%–100%).
Sample size calculation for the definitive RCT trial
For the definitive RCT we propose the primary outcome 
is the ODI at 26 weeks postrandomisation as the ODI 
has shown to be acceptable to patients and a commonly 
used measurement of self-rated disability. In this pilot 
trial, we observed a difference in means (in favour of 
the control group) of 2.5 points (95% CI  −4.5 to 9.1) 
between the randomised groups and an SD of 16 points 
at 26 weeks. There is a lack of consensus regarding the 
minimum clinically important difference for the ODI, 
with suggestions ranging from 6% to 30%.30 31 Table 4 
shows a range of sample sizes for varying target differ-
ences in the ODI. If we assume a target difference of 
five points on the ODI scale, then with 217 patients per 
group (434 in total) we would have 90% power to detect 
a five-point difference or more (equivalent to stan-
dardised effect size of 0.31) between the randomised 
groups which would be statistically significant at the 5% 
two-sided level. Allowing for a conservative estimate of 
20% attrition (we observed 15% in this pilot), we would 
need to recruit and randomise 272 per group (544 in 
total).
Based on the recruitment rates observed in this trial 
of 80 patients in 8.5 months of recruitment at 10 centres 
(a rate of 0.9 patients per centre month), the main trial 
would need around 24 centres recruiting for 24 months 
to achieve this target.
Domain
No of participants 
receiving 
component n=69
Method of 
assessment Treatment options
Frequency of 
component 
used %
Movement control43 33 (48%) Clinical 
assessment
1. Sagittal plane control in functional positions relevant to 
patients’ problems/goals
24 2.0
2. Coronal plane control in functional positions relevant to 
patients’ problems/goals
15 1.2
3. Axial plane control in functional positions relevant to 
patients’ problems/goals
1 0.1
4. Multiplanar control in functional positions relevant to 
patients’ problems/goals
6 0.5
5. Movement re-education in functional positions relevant 
to patients’ problems/goals
18 1.5
Pain44–46 52 (75%) ODI
VAS back and leg
clinical 
interview and 
history
1. Analgesic review and advice in liaison with GP/
Pharmacist
23 1.9
2. Pain education 60 5.0
3. Pain coping strategies 20 1.7
4. Fear reduction intervention in liaison with psychologist/
pain clinic
12 1.0
5. Stress reduction intervention in liaison with 
psychologist/pain clinic
32 2.7
Totals 1267 99.8%*
*0.2% missing data, two treatment episodes where components not attributed.
GP, general practitioner; LRS, lumbar radicular syndrome; ODI, Oswestry Disability Index; VAS, Visual Analogue Scale. 
Table 3 Continued 
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dIsCussIOn
This pilot study is the first to explore the role of early 
intervention physiotherapy for LRS. The study aimed to 
determine the feasibility of carrying out a full-scale RCT 
to determine the effectiveness of early physiotherapy 
for LRS. All of the feasibility parameters were found 
to be acceptable, including the set-up of GP centres to 
recruit participants, recruitment of participants and 
the retention of 85% of participants at 26 weeks. Both 
groups received the intervention at the appropriate 
time, within 2 weeks of randomisation for the early 
intervention physiotherapy group and after 6 weeks for 
the usual care group. The acceptance of the interven-
tion, judged by the rate of attendance by participants 
at their treatment sessions, was better than anticipated.
There were some limitations to this study. First, 
although recruitment was satisfactory and ahead of 
time, the GPs involved in the study were well motivated 
and supportive of the study, in a city with a proven 
track record of GP involvement in service develop-
ment and research. This may not be the case across the 
country and further afield. Similarly, the support of the 
service provider clinical, administrative and manage-
ment staff was a key factor in the success of the study, a 
factor which may not be reproducible in other centres. 
Patients self-referred into the study after an introduc-
tion from their GP (a prerequisite for ethics approval) 
and so this group of patients may not be representative 
of a wider population. These factors need to be taken 
in account when planning a definitive study, and we 
have taken a more conservative view of attrition in the 
definitive sample size calculation. Our recommenda-
tions about recruitment also suggest including a wider 
geographical spread of GP centres to help meet the 
proposed recruitment rates. Site selection would need 
to consider current service provision and the ability to 
deliver the intervention in settings that are convenient 
and accessible to patients. The reliance on a clinical 
diagnosis of LRS made by the GP and physiotherapists 
is a potential limitation. The limitation being that 
there is likely to be a degree of diagnostic heteroge-
neity within the sample using a pathoanatomical model 
of care. There is, therefore, potential that participants 
with LRS in the study may have symptoms from some-
thing other than nerve root inflammation, including 
pseudoradicular symptoms, somatic or visceral referred 
symptoms.
The strengths of the study are that it was a pragmatic 
study in a clinical setting, using clinical staff and avail-
able resources and as such represents the real world of 
the NHS. We demonstrated that the study is feasible 
and the potential of early intervention physiotherapy to 
improve patient care.
COnClusIOn
The POLAR study results indicate that a full-scale 
trial of early physiotherapy to treat patients with LRS 
is feasible. As there is a dearth of evidence about how 
and when best to treat this population, we conclude 
that a definitive trial is needed to help inform clinical 
practice.
Table 4 Sample sizes for main randomised controlled trial for a range of target mean differences with a primary outcome of 
the Oswestry Disability Index score at 26 weeks postrandomisation
Significance 
level (%)
Power 
(%) SD
Target mean 
difference
Standardised 
effect size
No in each 
group
Total sample 
size (N)
Total sample size drop-out
15% 20%
5 90 16 2 0.13 1346 2692 3168 3366
5 90 16 2.5 0.16 862 1724 2030 2156
5 90 16 3 0.19 599 1198 1410 1498
5 90 16 3.5 0.22 441 882 1038 1104
5 90 16 4 0.25 338 676 796 846
5 90 16 4.5 0.28 267 534 630 668
5 90 16 5 0.31 217 434 512 544
5 90 16 5.5 0.34 179 358 422 448
5 90 16 6 0.38 151 302 356 378
5 90 16 6.5 0.41 129 258 304 324
5 90 16 7 0.44 111 222 262 278
5 90 16 7.5 0.47 97 194 230 244
5 90 16 8 0.50 86 172 204 216
5 90 16 8.5 0.53 76 152 180 190
5 90 16 9 0.56 68 136 160 170
5 90 16 9.5 0.59 61 122 144 154
5 90 16 10 0.63 55 110 130 138
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